1/14/25 16:20 | 1/13/25 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lewis Karen | MA | O | Chief Pe | S | -46 | 28.70 | 0 | -2 | -3 | 45 | D | | | | | | | | | | | | | | |
1/31/24 16:28 | 1/29/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lewis Karen | MA | O | Chief Pe | S.m | -81 | 65.12 | 0 | -1 | -3 | 46 | D | | | | | | | | | | | | | | |
1/24/24 16:06 | 1/23/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lewis Karen | MA | O | Chief Pe | S | -273 | 63.69 | 0 | -4 | -8 | 48 | D | | | | | | | | | | | | | | |
1/23/24 18:07 | 1/22/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lewis Karen | MA | O | Chief Pe | S | -113 | 65.00 | 0 | -2 | -3 | 52 | D | | | | | | | | | | | | | | |
1/18/24 16:54 | 1/17/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lewis Karen | MA | O | Chief Pe | S | -215 | 65.58 | 0 | -3 | -6 | 54 | D | | | | | | | | | | | | | | |
1/17/24 16:43 | 1/16/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lewis Karen | MA | O | Chief Pe | S.d | -109 | 66.81 | 0 | -2 | -3 | 57 | D | | | | | | | | | | | | | | |
6/2/23 16:40 | 6/1/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lewis Karen | MA | O | Chief Pe | M.d | 171 | 34.11 | 0 | 5 | 14 | 42 | D | | | | | | | | | | | | | | |
6/2/23 16:40 | 6/1/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lewis Karen | MA | O | Chief Pe | S.d | -430 | 86.00 | 0 | -5 | -11 | 42 | D | | | | | | | | | | | | | | |
4/5/23 16:52 | 4/3/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lewis Karen | MA | O | Chief Pe | M.d | 171 | 34.11 | 0 | 5 | 14 | 41 | D | | | | | | | | | | | | | | |
4/5/23 16:52 | 4/3/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lewis Karen | MA | O | Chief Pe | S.d | -375 | 75.00 | 0 | -5 | -11 | 41 | D | | | | | | | | | | | | | | |
2/27/23 16:32 | 2/23/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lewis Karen | MA | O | Chief Pe | S | -76 | 68.76 | 0 | -1 | -3 | 41 | D | | | | | | | | | | | | | | |
1/31/23 16:47 | 1/30/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lewis Karen | MA | O | Chief Pe | S | -47 | 52.76 | 0 | -1 | -2 | 36 | D | | | | | | | | | | | | | | |
1/25/23 16:17 | 1/23/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lewis Karen | MA | O | Chief Pe | S | -152 | 51.58 | 0 | -3 | -7 | 38 | D | | | | | | | | | | | | | | |